Siemens Healthineers to Rebrand as Healthineers as Diagnostics Carve-Out Begins
By Adria Calatayud
Siemens Healthineers said it plans to rebrand as Healthineers, dropping Siemens from its name as the medical-technology company advances toward a spinoff from its parent group and kicks off a carve-out for its own diagnostics unit.
Healthineers said Thursday that its in vitro diagnostics business would rebrand as Olyrian Diagnostics as a first step toward establishing a standalone company. Both Healthineers' and the diagnostics unit's brand transitions will run in parallel, it added.
The moves come as German industrial giant Siemens looks to sharpen its focus on industrial artificial intelligence, reducing its exposure to a business in which it kept a major stake even after listing it on the stock market in 2018.
Siemens in 2025 laid out plans to deconsolidate Healthineers by spinning off a 30% stake to shareholders, cutting its ownership from around 67% currently. Healthineers said the spinoff would be submitted for shareholder approval at the annual general meetings of both companies in February.
The Healthineers brand migration is expected to start in 2027 and have a three-year transition period, while that of the diagnostics business is due to be completed by mid-2028, Healthineers said. The diagnostics unit will remain part of Healthineers during the transition, the company said.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
November 05, 2026 01:27 ET (06:27 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
These Overvalued Stocks Have Plenty of Room to Fall
4 Big Impacts from the US Midterm Elections for Investors
United States